Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    No substantial changes to core study details were observed; the page content remains essentially the same with only minor UI adjustments and timestamp updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-31T11:57:04.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Core content updated with a funding/operating status notice and a version upgrade from v3.0.2 to v3.2.0; no other substantive content changes detected.
    Difference
    2%
    Check dated 2025-10-02T19:43:23.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    No significant changes detected. The only modification is the removal of the 'Back to Top' link; core content and important details remain unchanged.
    Difference
    0.1%
    Check dated 2025-09-18T06:43:55.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Version updated from v3.0.0-post.1-g752effb-HEAD to v3.0.2; no substantive changes to content.
    Difference
    0.0%
    Check dated 2025-09-11T02:10:25.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated to a new version, v3.0.0-post.1-g752effb-HEAD, indicating a revision in the content. The 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-03T22:16:48.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, particularly in various countries, while some previously listed locations have been removed. Additionally, new publications related to Deucravacitinib have been added, enhancing the page's content on this treatment.
    Difference
    33%
    Check dated 2025-08-27T17:50:22.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.